Amanote Research
Register
Sign In
Dynamic Changes of Live/Apoptotic Circulating Tumour Cells as Predictive Marker of Response to Sunitinib in Metastatic Renal Cancer
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.2012.388
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
September 6, 2012
Authors
E Rossi
M Fassan
M Aieta
F Zilio
R Celadin
M Borin
A Grassi
L Troiani
U Basso
C Barile
T Sava
C Lanza
L Miatello
A Jirillo
M Rugge
S Indraccolo
M Cristofanilli
A Amadori
R Zamarchi
Publisher
Springer Science and Business Media LLC
Related search
Tumor Endothelial ELTD1 as a Predictive Marker for Treatment of Renal Cancer Patients With Sunitinib
BMC Cancer
Cancer Research
Oncology
Genetics
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Journal of Cancer
Oncology
Circulating Tumor and Endothelial Cells as Predictors of Response in Metastatic Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Circulating Tumour Cells and Hypercoagulability: A Lethal Relationship in Metastatic Breast Cancer
Clinical and Translational Oncology
Medicine
Cancer Research
Oncology
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer
Clinical and Investigative Medicine
Medicine
Circulating Tumour Cells and DNA as Liquid Biopsies in Gastrointestinal Cancer
British Journal of Surgery
Surgery
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
